Table 2

Percentage (numbers) of patients with rapid radiological damage progression (SHS >5 points) in the first year of the study categorised according to the ‘mean’ disease activity level between 3 months and 1 year for all indices (n=386)

RemissionLDAMDAHDA
DAS9.9 (8/81)11.0 (13/118)19.2 (28/146)39.0 (16/41)
DAS PGA10.3 (8/78)11.9 (14/118)18.4 (27/147)37.2 (16/43)
DAS 0–1 GH9.9 (8/81)10.9 (13/119)20.5 (31/151)37.1 (13/35)
DAS 0–1 PGA10.3 (8/78)11.6 (14/121)20.0 (30/150)35.1 (13/37)
DAS TJC53 GH9.1 (6/66)12.3 (13/106)16.6 (25/151)33.3 (21/63)
DAS TJC53 PGA10.3 (7/68)11.4 (12/105)17.3 (26/150)31.7 (20/63)
DAS TJC44 GH11.0 (8/73)11.1 (12/108)19.0 (28/147)29.3 (17/58)
DAS TJC44 PGA10.7 (8/75)11.5 (12/104)17.7 (26/147)31.7 (19/60)
DAS2812.1 (13/107)8.3 (5/60)17.2 (29/169)36.0 (18/50)
DAS28 PGA11.2 (12/107)8.2 (5/61)18.0 (30/167)35.3 (18/51)
  • DAS, disease activity score; GH, visual analogue scale for patient's assessment of general health; HDA, high disease activity; LDA; low disease activity; MDA, moderate disease activity; PGA, visual analogue scale of patient's global assessment of disease activity; SHS, Sharp van der Heijde score; TJC, tender joint count.